| 000 | 01800 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515123732.0 | ||
| 264 | 0 | _c20080915 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a0304-3940 | ||
| 024 | 7 |
_a10.1016/j.neulet.2008.05.067 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aImamura, Keiko | |
| 245 | 0 | 0 |
_aPramipexole has astrocyte-mediated neuroprotective effects against lactacystin toxicity. _h[electronic resource] |
| 260 |
_bNeuroscience letters _cAug 2008 |
||
| 300 |
_a97-102 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcysteine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAstrocytes _xcytology |
| 650 | 0 | 4 |
_aBenzothiazoles _xpharmacology |
| 650 | 0 | 4 |
_aBrain-Derived Neurotrophic Factor _xmetabolism |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCysteine Proteinase Inhibitors _xtoxicity |
| 650 | 0 | 4 |
_aDopamine Agonists _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aMicrotubule-Associated Proteins _xmetabolism |
| 650 | 0 | 4 |
_aNeurons _xcytology |
| 650 | 0 | 4 | _aPramipexole |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Dopamine D1 _xagonists |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xagonists |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
| 700 | 1 | _aTakeshima, Takao | |
| 700 | 1 | _aNakaso, Kazuhiro | |
| 700 | 1 | _aIto, Satoru | |
| 700 | 1 | _aNakashima, Kenji | |
| 773 | 0 |
_tNeuroscience letters _gvol. 440 _gno. 2 _gp. 97-102 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neulet.2008.05.067 _zAvailable from publisher's website |
| 999 |
_c18040671 _d18040671 |
||